PTBI Insider Trading Activity and SEC Form 4 Filings
PTBI insider trading summary
No open-market insider purchases or sales of Plasmatech Biopharmaceuticals Inc (PTBI) have been reported on SEC Form 4 in the past 12 months.
Latest PTBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 26, 2015 | Mark J Ahn | Director | Buy | $100K (25,000 @ $4.00) |
| Dec 24, 2014 | Beach Capital LLC | 10% Owner | Buy | $1.0M (250,000 @ $4.00) |
| Dec 24, 2014 | Steven H Rouhandeh | Director | Buy | $1.0M (250,000 @ $4.00) |
| Dec 24, 2014 | Sco Capital Partners LLC | 10% Owner | Buy | $1.0M (250,000 @ $4.00) |
| Dec 24, 2014 | B Davis Jeffrey | Director | Buy | $250K (62,500 @ $4.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.